作者: D. Azria , H. Auvray , I. Barillot , P. Baumann , A. Benyoucef
DOI: 10.1016/J.CANRAD.2008.07.005
关键词:
摘要: Ductal carcinoma in situ is defined as breast cancer confined to the ducts of without evidence penetration basement membrane. Local treatment quality represents one most prognostic factors half recurrences are invasive diseases. The main goal adjuvant radiotherapy after conservative surgery decrease local and permit conservation with low treatment-induced sequelae. Several randomized trials have established impact 50 Gy whole terms control. Nevertheless, no trial still available concerning role boost this disease. In review, we present updated results literature detail French multicentric evaluating a 16 delivered 25 fractions 33 days. This protocol will start inclusions October 2008.